![Michael Burgess](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Burgess
Direttore/Membro del Consiglio presso
iOmx Therapeutics AG
Profilo
Michael M.
Burgess currently works at The Royal College of Physicians, as Member, The Royal College of Paediatrics & Child Health, as Member, and iOmx Therapeutics AG, as Member-Supervisory Board from 2022.
Dr. Burgess also formerly worked at Turnstone Biologics Corp., as Director from 2024 to 2025, Synlogic, Inc., as Independent Director from 2020 to 2024, Bristol Myers Squibb Co., as SVP-Discovery Medicine & Clinical Pharmacology, Roche Holding AG, as Head-Oncology Discovery & Translational Area in 2012, Hoffmann-La Roche, Inc., as Global Head-DTA Oncology Division, Roche Holding (UK) Ltd., as Head-Clinical Research Division in 2010, Roche Ltd., as Head-Oncology Discovery & Translational Area, and Springworks Therapeutics, Inc., as Head-Research & Development from 2021 to 2022.
Dr. Burgess received his graduate degree in 1989 from the University of Bristol and doctorate degree in 1999 from the University of Bristol.
Posizioni attive di Michael Burgess
| Società | Posizione | Inizio |
|---|---|---|
The Royal College of Physicians
 The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
The Royal College of Paediatrics & Child Health
 The Royal College of Paediatrics & Child Health Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
iOmx Therapeutics AG
 iOmx Therapeutics AG BiotechnologyHealth Technology Develops immunotherapy treatments for cancer patients | Direttore/Membro del Consiglio | 20/07/2022 |
Precedenti posizioni note di Michael Burgess
| Società | Posizione | Fine |
|---|---|---|
| TURNSTONE BIOLOGICS CORP. | Direttore Tecnico/Scientifico/R&S | 01/11/2024 |
| SYNLOGIC, INC. | Direttore/Membro del Consiglio | 20/03/2024 |
| SPRINGWORKS THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 16/09/2022 |
Roche Holding (UK) Ltd.
 Roche Holding (UK) Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and sells drugs | Corporate Officer/Principal | 01/01/2010 |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Operates as a biotech company that develops pharmaceutical and diagnostic solutions | Corporate Officer/Principal | - |
Formazione di Michael Burgess
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
90
Relazioni di 1° grado
12
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 12 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Roche Holding AG
 Roche Holding AG Pharmaceuticals: MajorHealth Technology Operates as a research-focused healthcare company with combined focus in pharmaceuticals and diagnostics | Health Technology |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Operates as a biotech company that develops pharmaceutical and diagnostic solutions | Health Technology |
University of Bristol
 University of Bristol Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Roche Holding (UK) Ltd.
Roche Holding (UK) Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and sells drugs | Health Technology |
The Royal College of Physicians
The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Roche Ltd.
 Roche Ltd. Financial ConglomeratesFinance Provides investment services | Finance |
The Royal College of Paediatrics & Child Health
The Royal College of Paediatrics & Child Health Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
iOmx Therapeutics AG
iOmx Therapeutics AG BiotechnologyHealth Technology Develops immunotherapy treatments for cancer patients | Health Technology |
Synlogic, Inc.
 Synlogic, Inc. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
Turnstone Biologics Corp.
 Turnstone Biologics Corp. BiotechnologyHealth Technology Develops and sells medicines to treat and cure solid tumors | Health Technology |
Springworks Therapeutics, Inc.
 Springworks Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and commercializes medicines for nervous system disorders | Health Technology |
